原发性肝癌TACE治疗后并发肝衰竭相关因素分析  

Analysis of Hepatic Failure of Primary Liver Cancer after TACE

作　　者：王东盛[1] 陆英[1] 王成纲[1] 刘明[1] 刘海洋[1] 

机构地区：[1]北京煤炭总医院介入科,北京100028

出　　处：《中国医药导刊》2010年第10期1704-1706,共3页Chinese Journal of Medicinal Guide

摘　　要：目的:探讨原发性肝癌患者行肝动脉化疗栓塞(transcatheter arterial chemoembolization,TACE)治疗后,发生肝脏功能衰竭的原因。方法:对237例原发性肝癌TACE治疗后患者进行多因素回顾分析、总结。结果:在237例行TACE治疗原发性肝癌患者中,有28例发生肝脏功能衰竭。肝衰竭的发生与肝硬化、门静脉癌栓、手术方式、碘化油用量、乙型肝炎病毒DNA数量等因素有关。结论:多因素分析可更准确判断原发性肝癌患者行TACE治疗的预后。Objective：To study the cause of hepatic failure of primary, liver cancer after TACE.Methods：Multivariate analysis of data of 237 patients with primary liver cancer who were treated by TACE.Results：Of 237 patients, 28 patients had hepatic failure after TACE, There was a closely correlation between hepatic failure and cirrhosis and portal vein tumor thrombosis and operation and dose of Iodized oil and quantity of HBV-DNA.Conelusion：Multivadate analysis of clinieal data could estimate prognosis of patients with primary liver cancer after TACE.

关 键 词：原发性肝癌 肝衰竭 经导管动脉化疗栓塞 预后 评估 

分 类 号：R735.7[医药卫生—肿瘤] R575.3[医药卫生—临床医学]